Suppr超能文献

可生物降解纳米颗粒药物递送系统在肺部的促炎潜力研究。

Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung.

作者信息

Dailey L A, Jekel N, Fink L, Gessler T, Schmehl T, Wittmar M, Kissel T, Seeger W

机构信息

Department of Pharmaceutics and Biopharmacy, Philipps-University, D-35037 Marburg, Germany.

出版信息

Toxicol Appl Pharmacol. 2006 Aug 15;215(1):100-8. doi: 10.1016/j.taap.2006.01.016. Epub 2006 Mar 21.

Abstract

Particulate nanocarriers have been praised for their advantageous drug delivery properties in the lung, such as avoidance of macrophage clearance mechanisms and long residence times. However, instilled non-biodegradable polystyrene nanospheres with small diameters and thus large surface areas have been shown to induce pulmonary inflammation. This study examines the potential of biodegradable polymeric nanoparticles composed of poly(lactic-co-glycolic acid) (PLGA) and the novel PLGA derivative, diethylaminopropylamine polyvinyl alcohol-grafted-poly(lactic-co-glycolic acid) (DEAPA-PVAL-g-PLGA), to provoke inflammatory responses in the murine lung after intratracheal instillation. Lactate dehydrogenase (LDH) release, protein concentration, MIP-2 mRNA induction, and polymorphonucleocyte (PMN) recruitment in the bronchial alveolar lavage fluid (BALF) were used to evaluate an inflammatory response in Balb-C mice. Two sizes of polystyrene (PS) nanospheres (diameters: 75 nm and 220 nm) were included in the study for comparison. All nanoparticle suspensions were instilled at concentrations of 1 microg/microl and 2.5 microg/microl, representative of an estimated "therapeutic dose" and a concentrated "dose" of particles. In all experiments, the 75 nm PS particles exhibited elevated responses for the inflammatory markers investigated. In contrast, biodegradable particles of comparable hydrodynamic diameter showed a significantly lower inflammatory response. The most marked differences were observed in the extent of PMN recruitment. While the 75 nm and 220 nm PS nanospheres exhibited 41 and 74% PMN within the total BALF cell population after 24 h, respectively, PMN recruiting in lungs instilled with both types of biodegradable particles did not exceed values of the negative isotonic glucose control. In conclusion, evidence suggests that biodegradable polymeric nanoparticles designed for pulmonary drug delivery may not induce the same inflammatory response as non-biodegradable polystyrene particles of comparable size.

摘要

颗粒纳米载体因其在肺部具有有利的药物递送特性而受到赞誉,比如可避免巨噬细胞清除机制并具有较长的停留时间。然而,已证实经气管内滴注的小直径(因而具有大表面积)的不可生物降解聚苯乙烯纳米球会诱发肺部炎症。本研究考察了由聚乳酸 - 乙醇酸共聚物(PLGA)和新型PLGA衍生物二乙氨基丙胺聚乙烯醇接枝聚乳酸 - 乙醇酸共聚物(DEAPA - PVAL - g - PLGA)组成的可生物降解聚合物纳米颗粒在气管内滴注后诱发小鼠肺部炎症反应的可能性。采用支气管肺泡灌洗液(BALF)中的乳酸脱氢酶(LDH)释放量、蛋白质浓度、MIP - 2 mRNA诱导情况以及多形核白细胞(PMN)募集情况来评估Balb - C小鼠的炎症反应。研究中纳入了两种尺寸的聚苯乙烯(PS)纳米球(直径分别为:75 nm和220 nm)用于比较。所有纳米颗粒悬浮液均以1 μg/μl和2.5 μg/μl的浓度进行滴注,这分别代表估计的“治疗剂量”和浓缩的“剂量”颗粒。在所有实验中,75 nm的PS颗粒在所研究的炎症标志物方面表现出升高的反应。相比之下,具有相当流体动力学直径的可生物降解颗粒显示出明显较低的炎症反应。在PMN募集程度方面观察到最显著的差异。24小时后,75 nm和220 nm的PS纳米球在总BALF细胞群体中分别显示出41%和74%的PMN,而用两种可生物降解颗粒滴注的肺部中PMN募集未超过阴性等渗葡萄糖对照的值。总之,有证据表明设计用于肺部药物递送的可生物降解聚合物纳米颗粒可能不会诱发与尺寸相当的不可生物降解聚苯乙烯颗粒相同的炎症反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验